Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00570427 · ClinicalTrials.gov registry record · NA

Improving Depression Treatment for Older Minority Adults

A NA study, sponsored by National Institute on Aging (NIA).

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT00570427: Completed NA study, sponsored by National Institute on Aging (NIA).

NCT00570427 is a NA study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00570427, a NA study, has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The purpose of this study is to improve access to quality depression care for older, low-income, minority adults in public sector health care. The study will examine current depression care in a public sector geriatric clinic that serves mostly Spanish-speaking Latinos and pilot study assessments and treatments in order to lay the groundwork for a large study of quality improvement for depressed older minorities

Interventions

  • BEHAVIORAL Problem Solving Therapy (PST)
  • BEHAVIORAL Medication Management

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2007-02
Est. Completion 2008-06
Phase NA
National Institute on Aging (NIA)

131 total trials

What the finished NCT00570427 record still lists

NCT00570427 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Problem Solving Therapy (PST) is the first listed.

NCT00570427 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00570427 about?

NCT00570427 is a clinical study titled "Improving Depression Treatment for Older Minority Adults". The purpose of this study is to improve access to quality depression care for older, low-income, minority adults in public sector health care. The study will examine current depression care in a public sector geriatric clinic that serves mostly Spanish-speaking Latinos and pilot study assessments an...

What is the current status of trial NCT00570427?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2007-02. Estimated completion is 2008-06.

What interventions are being tested in trial NCT00570427?

The interventions under investigation include: Problem Solving Therapy (PST) (BEHAVIORAL), Medication Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT00570427?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00570427's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00570427, the US trial registry maintained by the National Library of Medicine. NCT00570427 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.